MJA
MJA

Lifestyle advice from general practitioners and changes in health‐related behaviour in Australia: secondary analysis of 2020–21 National Health Survey data

Loai Albarqouni, Hannah Greenwood, Caroline Dowsett and Paul P Glasziou
Med J Aust || doi: 10.5694/mja2.52285
Published online: 6 May 2024

Lifestyle factors — smoking, alcohol consumption, inadequate dietary levels of fruit and vegetables — are major risk factors for chronic medical conditions.1 The importance of clinicians encouraging people to modify their lifestyles is emphasised in many guidelines.2 A study that included 4716 American adults found that patient‐reported lifestyle advice from their doctors was associated with corresponding behavioural changes (weight reduction, increased physical activity).3 How often Australian general practitioners provide their patients with lifestyle advice and whether such advice is effective are unknown.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.

Online responses are no longer available. Please refer to our instructions for authors page for more information.

Symptomatic cancer diagnosis in general practice: a critical perspective of current guidelines and risk assessment tools

Brent Venning and Jon D Emery
Med J Aust || doi: 10.5694/mja2.52287
Published online: 6 May 2024

On 2 November 2023, Cancer Australia unveiled the Australian Cancer Plan, emphasising a strategic commitment to “maximising cancer prevention and early detection”.1,2 This initiative holds particular significance for general practice, as most cancer diagnoses originate from symptomatic presentations to primary care, even when screening programs are available.3 For context, full‐time general practitioners on average diagnose up to 12 non‐cutaneous cancers annually, but they see patients consulting with symptoms associated with cancer almost daily.3,4

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • Centre for Cancer Research, University of Melbourne, Melbourne, VIC



Open access:

Open access publishing facilitated by The University of Melbourne, as part of the Wiley ‐ The University of Melbourne agreement via the Council of Australian University Librarians.


Acknowledgements: 

Brent Venning is supported by the Melbourne Academic Centre for Health (MACH) through the MACH‐Track program and by a University of Melbourne Research Training Program Scholarship. Jon Emery is supported by a National Health and Medical Research Council Investigator Grant (APP1195302) and is an Associate Director of the CanTest Collaborative (funded by Cancer Research UK, C8640/A23385).

Competing interests:

No relevant disclosures.

  • 1. Cancer Australia. Australian Cancer Plan [website]. Canberra: Commonwealth of Australia, 2021. https://www.canceraustralia.gov.au/australian‐cancer‐plan (viewed Nov 2023).
  • 2. Chaji D, Boltong A, Der Vartanian C, et al. Setting the policy agenda for cancer control reform: Australia's first national cancer control plan. Med J Aust 2023; 219: 451‐454. https://www.mja.com.au/journal/2023/219/10/setting‐policy‐agenda‐cancer‐control‐reform‐australias‐first‐national‐cancer
  • 3. Emery JD. The challenges of early diagnosis of cancer in general practice. Med J Aust 2015; 203: 391‐393. https://www.mja.com.au/journal/2015/203/10/challenges‐early‐diagnosis‐cancer‐general‐practice
  • 4. Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract 2010; 60: 121‐128.
  • 5. Rubin G, Berendsen A, Crawford SM, et al. The expanding role of primary care in cancer control. Lancet Oncol 2015; 16: 1231‐1272.
  • 6. Koo MM, Hamilton W, Walter FM, et al. Symptom signatures and diagnostic timeliness in cancer patients: a review of current evidence. Neoplasia 2018; 20: 165‐174.
  • 7. Stapley S, Peters TJ, Neal RD, et al. The risk of pancreatic cancer in symptomatic patients in primary care: a large case‐control study using electronic records. Br J Cancer 2012; 106: 1940‐1944.
  • 8. Jensen H, Tørring ML, Olesen F, et al. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population‐based GP survey and registry study. BMC Cancer 2014; 14: 636.
  • 9. McGarvey N, Gitlin M, Fadli E, Chung KC. Increased healthcare costs by later stage cancer diagnosis. BMC Health Serv Res 2022; 22: 1155.
  • 10. Emery JD, Shaw K, Williams B, et al. The role of primary care in early detection and follow‐up of cancer. Nat Rev Clin Oncol 2014; 11: 38‐48.
  • 11. Renzi C, Kaushal A, Emery J, et al. Comorbid chronic diseases and cancer diagnosis: disease‐specific effects and underlying mechanisms. Nat Rev Clin Oncol 2019; 16: 746‐761.
  • 12. Brownlee S, Chalkidou K, Doust J, et al. Evidence for overuse of medical services around the world. Lancet 2017; 390: 156‐168.
  • 13. Lyratzopoulos G, Vedsted P, Singh H. Understanding missed opportunities for more timely diagnosis of cancer in symptomatic patients after presentation. Br J Cancer 2015; 112 (Suppl): S84‐S91.
  • 14. Banks J, Hollinghurst S, Bigwood L, et al. Preferences for cancer investigation: a vignette‐based study of primary‐care attendees. Lancet Oncol 2014; 15: 232‐240.
  • 15. Venning B, Pearce A, Lourenco RDA, et al. Patient preferences for investigating cancer‐related symptoms in australian general practice: a discrete choice experiment. Br J Gen Pract 2024; https://doi.org/10.3399/BJGP.2023.0583 [Epub ahead of print].
  • 16. Cancer Australia. Optimal Care Pathways. Canberra: Commonwealth of Australia, 2024. https://www.canceraustralia.gov.au/optimal‐cancer‐care‐pathways (viewed Apr 2024).
  • 17. Cancer Australia. Optimal Care Pathways: for general practitioners and primary care staff — I‐PACED (Implementing Pathways for Cancer Early Diagnosis). Canberra: Commonwealth of Australia, 2024. https://www.cancervic.org.au/get‐support/for‐health‐professionals/optimal‐care‐pathways (viewed Apr 2024).
  • 18. Cancer Australia. GP guides and resources. https://www.canceraustralia.gov.au/clinical‐best‐practice/gynaecological‐cancers/gp‐guides‐and‐resources. Canberra: Commonwealth of Australia, 2021. (viewed Apr 2024).
  • 19. Chiang PPC, Glance D, Walker J, et al. Implementing a QCancer risk tool into general practice consultations: an exploratory study using simulated consultations with Australian general practitioners. Br J Cancer 2015; 112 (Suppl): S77‐S83.
  • 20. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral [NICE guideline NG12; updated Oct 2023]. Manchester (UK): NICE, 2015. https://www.nice.org.uk/guidance/ng12 (viewed Mar 2024).
  • 21. Conroy T, Pfeiffer P, Vilgrain V, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow‐up. Ann Oncol 2023; 34: 987‐1002.
  • 22. Hamilton W. The CAPER studies: five case‐control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer 2009; 101 (Suppl): S80‐S86.
  • 23. Hamilton W, Green T, Martins T, et al. Evaluation of risk assessment tools for suspected cancer in general practice: a cohort study. Br J Gen Pract 2013; 63: e30‐e36.
  • 24. Price S, Spencer A, Medina‐Lara A, Hamilton W. Availability and use of cancer decision‐support tools: a cross‐sectional survey of UK primary care. Br J Gen Pract 2019; 69: e437‐e443.
  • 25. Hamilton W, Mounce L, Abel GA, et al. Protocol for a pragmatic cluster randomised controlled trial assessing the clinical effectiveness and cost‐effectiveness of Electronic RIsk‐assessment for CAncer for patients in general practice (ERICA). BMJ Open 2023; 13: e065232.
  • 26. Royal Australian College of General Practitioners. Electronic clinical decision support in general practice [website]. Melbourne: RACGP, 2024. https://www.racgp.org.au/advocacy/position‐statements/view‐all‐position‐statements/clinical‐and‐practice‐management/electronic‐clinical‐decision‐support (viewed Mar 2024).
  • 27. Chima S, Reece JC, Milley K, et al. Decision support tools to improve cancer diagnostic decision making in primary care: a systematic review. Br J Gen Pract 2019; 69: e809‐e818.
  • 28. Hunter B, Biezen R, Alexander K, et al. Future Health Today: codesign of an electronic chronic disease quality improvement tool for use in general practice using a service design approach. BMJ Open 2020; 10: e040228.
  • 29. Davies D, Morgan M, de Wet C. Supporting quality and safety in general practice: Response rates to computer decision support. Aust J Gen Pract 2022; 51: 884‐892.
Online responses are no longer available. Please refer to our instructions for authors page for more information.

How should artificial intelligence be used in Australian health care? Recommendations from a citizens’ jury

Stacy M Carter, Yves Saint James Aquino, Lucy Carolan, Emma Frost, Chris Degeling, Wendy A Rogers, Ian A Scott, Katy JL Bell, Belinda Fabrianesi and Farah Magrabi
Med J Aust 2024; 220 (8): . || doi: 10.5694/mja2.52283
Published online: 6 May 2024

Abstract

Objective: To support a diverse sample of Australians to make recommendations about the use of artificial intelligence (AI) technology in health care.

Study design: Citizens’ jury, deliberating the question: “Under which circumstances, if any, should artificial intelligence be used in Australian health systems to detect or diagnose disease?”

Setting, participants: Thirty Australian adults recruited by Sortition Foundation using random invitation and stratified selection to reflect population proportions by gender, age, ancestry, highest level of education, and residential location (state/territory; urban, regional, rural). The jury process took 18 days (16 March – 2 April 2023): fifteen days online and three days face‐to‐face in Sydney, where the jurors, both in small groups and together, were informed about and discussed the question, and developed recommendations with reasons. Jurors received extensive information: a printed handbook, online documents, and recorded presentations by four expert speakers. Jurors asked questions and received answers from the experts during the online period of the process, and during the first day of the face‐to‐face meeting.

Main outcome measures: Jury recommendations, with reasons.

Results: The jurors recommended an overarching, independently governed charter and framework for health care AI. The other nine recommendation categories concerned balancing benefits and harms; fairness and bias; patients’ rights and choices; clinical governance and training; technical governance and standards; data governance and use; open source software; AI evaluation and assessment; and education and communication.

Conclusions: The deliberative process supported a nationally representative sample of citizens to construct recommendations about how AI in health care should be developed, used, and governed. Recommendations derived using such methods could guide clinicians, policy makers, AI researchers and developers, and health service users to develop approaches that ensure trustworthy and responsible use of this technology.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 University of Wollongong, Wollongong, NSW
  • 2 Australian Centre for Health Engagement, Evidence and Values, University of Wollongong, Wollongong, NSW
  • 3 Macquarie University, Sydney, NSW
  • 4 University of Queensland, Brisbane, QLD
  • 5 Princess Alexandra Hospital, Brisbane, QLD
  • 6 University of Sydney, Sydney, NSW
  • 7 Australian Institute for Health Innovation, Macquarie University, Sydney, NSW


Correspondence: stacyc@uow.edu.au


Open access:

Open access publishing facilitated by University of Wollongong, as part of the Wiley – University of Wollongong agreement via the Council of Australian University Librarians.


Data sharing:

Individual deidentified participant data will be partially shared. The ethics approval for the study stipulated that transcripts of recordings of the jurors’ deliberations would remain confidential because of the risk of individual identification. Our study did not involve data dictionaries. Extensive information about the study protocol, and data generated for and in the study (including descriptions of the process, the expert witness videos, questions generated by the jury, and answers provided by the experts) are available at https://uow.info/TAWSYN_JURY.


Acknowledgements: 

This study was supported by the National Health and Medical Research Council (1181960).

Competing interests:

No relevant disclosures.

Online responses are no longer available. Please refer to our instructions for authors page for more information.

Towards national paediatric clinical practice guidelines

Mike Starr
Med J Aust || doi: 10.5694/mja2.52272
Published online: 15 April 2024

Clinical practice guidelines (CPGs) are intended to improve the quality of clinical care by promoting evidence‐based care, reducing inappropriate variation, and producing optimal outcomes for patients.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 Royal Children's Hospital, Melbourne, VIC
  • 2 University of Melbourne, Melbourne, VIC


Correspondence: mike.starr@rch.org.au


Open access:

Open access publishing facilitated by The University of Melbourne, as part of the Wiley ‐ The University of Melbourne agreement via the Council of Australian University Librarians.


Acknowledgements: 

The PIC CPG work is funded in part by Clinical Excellence Queensland, the NSW Agency for Clinical Innovation, Safer Care Victoria, RCH Melbourne, and the RCH Foundation. Kate Harding, Matthew O'Meara and Mike South have had an integral role in the work of the CPG committee and PIC steering committee.

Competing interests:

No relevant disclosures.

  • 1. Cohn SL, Gautam B, Preddy JS, et al. Barriers to the use of paediatric clinical practice guidelines in rural and regional New South Wales Australia. Aust J Rural Health 2016; 24, 23‐28.
  • 2. Braithwaite J, Hibbert PD, Jaffe A, et al. Quality of health care for children in Australia, 2012‐2013. JAMA 2018; 319: 1113‐1124.
  • 3. Duggan A, Koff E, Marshall V. Clinical variation: why it matters. Med J Aust 2016; 205: S3‐S4. https://www.mja.com.au/journal/2016/205/10/clinical‐variation‐why‐it‐matters
  • 4. Royal Children's Hospital Melbourne. Clinical Practice Guidelines: CPG information. https://www.rch.org.au/clinicalguide/about_rch_cpgs/CPG_information/ (viewed July 2023).
  • 5. Rea CJ, Alvarez FJ, Tieder JS. The silent crisis of pediatric clinical practice guidelines. JAMA Pediatr 2021; 175: 1201‐1202.
  • 6. Flores G, Lee M, Bauchner H. Pediatricians’ attitudes, beliefs, and practices regarding clinical practice guidelines: a national survey. Pediatrics 2000; 105: 496‐501.
Online responses are no longer available. Please refer to our instructions for authors page for more information.

Mainstreaming genomic testing: pre‐test counselling and informed consent

Michaela Cormack, Kathryn B Irving, Fiona Cunningham and Andrew P Fennell
Med J Aust || doi: 10.5694/mja2.52254
Published online: 8 April 2024

There is unprecedented, increasing demand for genomic testing in Australia.1,2 Recent developments in paediatric neurology alone include Medical Benefits Schedule, industry and research sponsored testing for monogenic causes of epilepsy, neuromuscular disorders, and syndromic intellectual disability, among others. To be ethically and legally valid, patients must undergo pre‐test counselling before they consent to genomic testing.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 Monash Health, Melbourne, VIC
  • 2 Royal Children's Hospital, Melbourne, VIC
  • 3 University of Melbourne, Melbourne, VIC
  • 4 Monash University, Melbourne, VIC



Consent for publication:

Consent for publication of the case study described and discussed in this article was obtained from both parents on behalf of the child.


Open access:

Open access publishing facilitated by Monash University, as part of the Wiley ‐ Monash University agreement via the Council of Australian University Librarians.


Competing interests:

No relevant disclosures.

  • 1. Fennell AP, Hunter MF, Corboy GP. The changing face of clinical genetics service delivery in the era of genomics: a framework for monitoring service delivery and data from a comprehensive metropolitan general genetics service. Genet Med 2020; 22: 210‐218.
  • 2. National Health and Medical Research Council. DNA genetic testing in the Australian context: a statement from the National Health and Medical Research Council (NHMRC). https://www.nhmrc.gov.au/sites/default/files/2022‐10/dna‐genetic‐testing‐in‐the‐australian‐context.pdf (viewed Sept 2023).
  • 3. Blackburn HL, Schroeder B, Turner C, et al. Management of incidental findings in the era of next‐generation sequencing. Curr Genomics 2015; 16: 159‐174.
  • 4. Meiser B, Irle J, Lobb E, Barlow‐Stewart K. Assessment of the content and process of genetic counseling: a critical review of empirical studies. J Genet Couns 2008; 17: 434‐451.
  • 5. Pacyna JE, Radecki Breitkopf C, Jenkins SM, et al. Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study. J Med Genet 2019; 56: 317‐324.
  • 6. Chair SY, Law BMH, Zang Y, et al. The effects of decision aids for genetic counselling among people considering genetic testing: a systematic review. J Clin Nurs 2023; 32: 6796‐6810.
  • 7. Stark Z, Dolman L, Manolio TA, et al. Integrating genomics into healthcare: a global responsibility. Am J Hum Genet 2019; 104: 13‐20.
  • 8. Otlowski MF, Williamson R. Ethical and legal issues and the “new genetics”. Med J Aust 2003; 178: 582‐585. https://www.mja.com.au/journal/2003/178/11/ethical‐and‐legal‐issues‐and‐new‐genetics
  • 9. Miller IO, Sotero de Menezes MA. SCN1A seizure disorders. 2007 [Updated 2022]. In: Adam MP, Mirzaa GM, Pagon RA, et al, editors. GeneReviews. Initial posting: 29 Nov 2007; last revision: 17 Feb 2022. https://www.ncbi.nlm.nih.gov/books/NBK1318/ (viewed Sept 2023).
  • 10. Li W, Schneider AL, Scheffer IE. Defining Dravet syndrome: an essential pre‐requisite for precision medicine trials. Epilepsia 2021; 62: 2205‐2217.
  • 11. Nisselle A, King E, Terrill B, et al. Investigating genomic medicine practice and perceptions amongst Australian non‐genetics physicians to inform education and implementation. NPJ Genom Med 2023; 8: 13.
  • 12. Uhlmann WR, Roberts JS. Ethical issues in neurogenetics. Handb Clin Neurol 2018; 147: 23‐36.
  • 13. Human Genetics Society of Australasia. Code of ethics for genetic counsellors. 2022. https://www.hgsa.org.au/documents/item/9589 (viewed Oct 2023).
  • 14. Tiller J, Lacaze P, Otlowski M. The Australian moratorium on genetics and life insurance: evaluating policy compared to Parliamentary recommendations regarding genetic discrimination. Public Health Res Pract 2022; 32: e3242235.
  • 15. Willcox D, Trent RJA, Lyons N, et al. Making good on the promise of genomics in healthcare: the NSW Health perspective. Aust Health Rev 2023; 47: 631‐633.
  • 16. King E, Halliday J, Archibald AD. et al. Development and use of the Australian reproductive genetic carrier screening decision aid. Eur J Hum Genet 2022; 30: 194‐202.
  • 17. Wright H, Zhao L, Birks M, Mills J. Genomic literacy of registered nurses, and midwives in Australia: a cross‐sectional survey. J Nurs Scholarsh 2019; 51: 40‐49.
Online responses are no longer available. Please refer to our instructions for authors page for more information.

Medicare‐funded reproductive genetic carrier screening in Australia has arrived: are we ready?

Alice P Rogers, Lara Fitzgerald, Jan Liebelt and Christopher Barnett
Med J Aust || doi: 10.5694/mja2.52261
Published online: 8 April 2024

Reproductive genetic carrier screening (RGCS) is a preventive health strategy performed to identify healthy couples and individuals who are at increased chance of having a child affected by a serious, childhood onset autosomal recessive or X‐linked genetic condition (Box 1).

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 SA Clinical Genetics Service, Women's and Children's Hospital, Adelaide, SA
  • 2 University of Adelaide, Adelaide, SA
  • 3 Repromed (Adelaide Fertility Centre), Adelaide, SA



Open access:

Open access publishing facilitated by The University of Adelaide, as part of the Wiley ‐ The University of Adelaide agreement via the Council of Australian University Librarians.


Competing interests:

Jan Liebelt and Lara Fitzgerald are employed by Repromed, whose laboratory offers preconception RGCS. They also provide genetic counselling services.

  • 1. Kaback MM, Nathan TJ, Greenwald S. Tay‐Sachs disease: heterozygote screening and prenatal diagnosis—US experience and world perspective. Prog Clin Biol Res 1977; 18: 13‐36.
  • 2. Watson EK, Mayall E, Chapple J, et al. Screening for carriers of cystic fibrosis through primary health care services. BMJ 1991; 303: 504‐507.
  • 3. Srinivasan BS, Evans EA, Flannick J, et al. A universal carrier test for the long tail of Mendelian disease. Reprod Biomed Online 2010; 21: 537‐551.
  • 4. Grody WW, Thompson BH, Gregg AR, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med 2013; 15: 482‐483.
  • 5. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Genetic carrier screening. Mar 2019. https://ranzcog.edu.au/wp‐content/uploads/2022/05/Genetic‐carrier‐screeningC‐Obs‐63New‐March‐2019_1.pdf (viewed Nov 2023).
  • 6. Haque IS, Lazarin GA, Kang HP, et al. Modeled fetal risk of genetic diseases identified by expanded carrier screening. JAMA 2016; 316: 734‐742.
  • 7. Archibald AD, Smith MJ, Burgess T, et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genet Med 2018; 20: 513‐523.
  • 8. Fridman H, Yntema HG, Mägi R, et al. The landscape of autosomal‐recessive pathogenic variants in European populations reveals phenotype‐specific effects. Am J Hum Genet 2021; 108: 608‐619.
  • 9. Best S, Long J, Theodorou T, et al. Health practitioners’ perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: a systematic review. Prenat Diagn 2021; 41: 708‐719.
  • 10. Goldberg JD, Pierson S, Johansen Taber K. Expanded carrier screening: what conditions should we screen for? Prenat Diagn 2023; 43: 496‐505.
  • 11. Gregg AR, Aarabi M, Klugman S, et al. Screening for autosomal recessive and X‐linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021; 23: 1793‐1806.
  • 12. Henneman L, Borry P, Chokoshvili D, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet 2016; 24: e1‐e12.
  • 13. Committee Opinion No. 690 summary: Carrier screening in the age of genomic medicine. Obstet Gynecol 2017; 129: e35‐e40.
  • 14. Grody WW, Cutting GR, Klinger KW, et al. Laboratory standards and guidelines for population‐based cystic fibrosis carrier screening. Genet Med 2001; 3: 149‐154.
  • 15. Massie J, Petrou V, Forbes R, et al. Population‐based carrier screening for cystic fibrosis in Victoria: the first three years experience. Aust N Z J Obstet Gynaecol 2009; 49: 484‐489.
  • 16. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073‐1080.
  • 17. Savant A, Lyman B, Bojanowski C, Upadia J. Cystic fibrosis. In: Adam MP, Feldman J, Mirzaa GM, et al, editors. GeneReviews. Initial posting: 26 Mar 2001; last revision: 9 Mar 2023. https://www.ncbi.nlm.nih.gov/books/NBK1250/ (viewed Nov 2023).
  • 18. Prior TW, Leach ME, Finanger E. Spinal muscular atrophy. In: Adam MP, Feldman J, Mirzaa GM, et al, editors. GeneReviews. Initial posting: 24 Feb 2000; last revision: 3 Dec 2020. https://www.ncbi.nlm.nih.gov/books/NBK1352/ (viewed Nov 2023).
  • 19. D'Silva AM, Kariyawasam DST, Best S, et al. Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme. Dev Med Child Neurol 2022; 64: 625‐632.
  • 20. Schofield D, Lee E, Parmar J, et al. Economic evaluation of population‐based, expanded reproductive carrier screening for genetic diseases in Australia. Genet Med 2023; 25: 100813.
  • 21. Delatycki MB, Laing NG, Moore SJ, et al. Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners. Aust J Gen Pract 2019; 48: 106‐110.
  • 22. Sparks TN. Expanded carrier screening: counseling and considerations. Hum Genet 2020; 139: 1131‐1139.
  • 23. Archibald AD, McClaren BJ, Caruana J, et al. The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): design and implementation. J Pers Med 2022; 12: 1781.
  • 24. Mackenzie's Mission. Outcomes of the Mackenzie's Mission study. https://www.mackenziesmission.org.au/outcomes/ (viewed Nov 2023).
Online responses are no longer available. Please refer to our instructions for authors page for more information.

The 2023 report of the MJALancet Countdown on health and climate change: sustainability needed in Australia's health care sector

Paul J Beggs, Stefan Trueck, Martina K Linnenluecke, Hilary Bambrick, Anthony G Capon, Ivan C Hanigan, Nicolas Borchers Arriagada, Troy J Cross, Sharon Friel, Donna Green, Maddie Heenan, Ollie Jay, Harry Kennard, Arunima Malik, Celia McMichael, Mark Stevenson, Sotiris Vardoulakis, Tran N Dang, Gail Garvey, Raymond Lovett, Veronica Matthews, Dung Phung, Alistair J Woodward, Marina B Romanello and Ying Zhang
Med J Aust || doi: 10.5694/mja2.52245
Published online: 25 March 2024

Summary

  • The MJALancet Countdown on health and climate change in Australia was established in 2017 and produced its first national assessment in 2018 and annual updates in 2019, 2020, 2021 and 2022. It examines five broad domains: health hazards, exposures and impacts; adaptation, planning and resilience for health; mitigation actions and health co‐benefits; economics and finance; and public and political engagement. In this, the sixth report of the MJALancet Countdown, we track progress on an extensive suite of indicators across these five domains, accessing and presenting the latest data and further refining and developing our analyses.
  • Our results highlight the health and economic costs of inaction on health and climate change. A series of major flood events across the four eastern states of Australia in 2022 was the main contributor to insured losses from climate‐related catastrophes of $7.168 billion — the highest amount on record. The floods also directly caused 23 deaths and resulted in the displacement of tens of thousands of people.
  • High red meat and processed meat consumption and insufficient consumption of fruit and vegetables accounted for about half of the 87 166 diet‐related deaths in Australia in 2021. Correction of this imbalance would both save lives and reduce the heavy carbon footprint associated with meat production.
  • We find signs of progress on health and climate change. Importantly, the Australian Government released Australia's first National Health and Climate Strategy, and the Government of Western Australia is preparing a Health Sector Adaptation Plan. We also find increasing action on, and engagement with, health and climate change at a community level, with the number of electric vehicle sales almost doubling in 2022 compared with 2021, and with a 65% increase in coverage of health and climate change in the media in 2022 compared with 2021.
  • Overall, the urgency of substantial enhancements in Australia's mitigation and adaptation responses to the enormous health and climate change challenge cannot be overstated. Australia's energy system, and its health care sector, currently emit an unreasonable and unjust proportion of greenhouse gases into the atmosphere. As the Lancet Countdown enters its second and most critical phase in the leadup to 2030, the depth and breadth of our assessment of health and climate change will be augmented to increasingly examine Australia in its regional context, and to better measure and track key issues in Australia such as mental health and Aboriginal and Torres Strait Islander health and wellbeing.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 Macquarie University, Sydney, NSW
  • 2 University of Technology Sydney, Sydney, NSW
  • 3 National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT
  • 4 Monash Sustainable Development Institute, Monash University, Melbourne, VIC
  • 5 Curtin University, Perth, WA
  • 6 Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS
  • 7 University of Sydney, Sydney, NSW
  • 8 Australian National University, Canberra, ACT
  • 9 Climate Change Research Centre and ARC Centre of Excellence for Climate Extremes, UNSW, Sydney, NSW
  • 10 Australian Prevention Partnership Centre, Sax Institute, Sydney, NSW
  • 11 The George Institute for Global Health, Sydney, NSW
  • 12 Thermal Ergonomics Laboratory, University of Sydney, Sydney, NSW
  • 13 Center on Global Energy Policy, Columbia University, New York, NY, USA
  • 14 University of Melbourne, Melbourne, VIC
  • 15 Transport, Health and Urban Design (THUD) Research Lab, University of Melbourne, Melbourne, VIC
  • 16 University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
  • 17 University of Queensland, Brisbane, QLD
  • 18 Australian Institute of Aboriginal and Torres Strait Islander Studies, Canberra, ACT
  • 19 University Centre for Rural Health, University of Sydney, Sydney, NSW
  • 20 University of Auckland, Auckland, NZ
  • 21 Institute for Global Health, University College London, London, UK


Correspondence: paul.beggs@mq.edu.au


Open access:

Open access publishing facilitated by Macquarie University, as part of the Wiley ‐ Macquarie University agreement via the Council of Australian University Librarians.


Acknowledgements: 

We thank Robert Fawcett, Justin Peter, and John Nairn (all from the Australian Bureau of Meteorology) for indicators 1.1 Exposure of vulnerable populations to heatwaves and 2.2 Climate information for health. Ivan Hanigan's access to data for indicators 1.4 and 3.3 was supported by the Centre for Air Pollution, Energy, and Health Research Data Platform funded by the NHMRC Centre for Safe Air (https://www.car‐cre.org.au/; https://cardat.github.io), which received funding from the Australian Research Data Commons for the Integrated National Air Pollution and Health Data project (https://doi.org/10.47486/PS022), and he acknowledges the HEAL (Healthy Environments And Lives) National Research Network, which receives funding from the NHMRC (grant no. 2008937). The Bushfires indicator was generated with support from NASA Applied Sciences Program (grant no. 80NSSC21K0507) and we thank Yang Liu and Qiao Zhu (Emory University) as well as Yun Hang (now at University of Texas Health Science Center) for the Australian data used for this indicator (1.3). We also thank Fay Johnston for assistance with this indicator. We thank Carole Dalin (University College London) for assistance with indicator 3.5 Emissions from agricultural production and consumption. We thank the Lancet Countdown for providing the results for indicators 3.6 Diet and health co‐benefits, and 3.7 Health care sector emissions. We thank the NHMRC for providing the data for indicator 5.4 Health and climate change research funding.

Competing interests:

No relevant disclosures.

Online responses are no longer available. Please refer to our instructions for authors page for more information.

Call to end shackling of hospitalised palliative prisoner patients

Lara Pemberton, Stacey Panozzo and Jennifer Philip
Med J Aust || doi: 10.5694/mja2.52240
Published online: 18 March 2024

In the face of an ageing prison population, there is growing pressure for correctional health staff to provide end‐of‐life care for the incarcerated.1 This article evaluates the literature and examines the practices surrounding the use of shackles and restraints in palliative prisoner patients cared for in the hospital setting. Although we recognise that the use of restraints is a reasonable strategy in certain circumstances to maintain community safety, it is not clear that age, illness or immobility are always factored into these decisions.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 Biomedicine Discovery Institute, Monash University, Melbourne, VIC
  • 2 St Vincent's Hospital Melbourne, Melbourne, VIC
  • 3 University of Melbourne, Melbourne, VIC


Correspondence: stacey.panozzo@svha.org.au


Open access:

Open access publishing facilitated by The University of Melbourne, as part of the Wiley ‐ The University of Melbourne agreement via the Council of Australian University Librarians.


Competing interests:

No relevant disclosures.

Online responses are no longer available. Please refer to our instructions for authors page for more information.

Expanding access to fracture liaison services in Australia for people with minimal trauma fractures: a system dynamics modelling study

Alicia R Jones, Danielle Currie, Cindy Peng, Peter R Ebeling, Jackie R Center, Gustavo Duque, Sean Lybrand, Greg Lyubomirsky, Rebecca J Mitchell, Sallie Pearson, Markus J Seibel and Jo‐An Occhipinti
Med J Aust 2024; 220 (5): . || doi: 10.5694/mja2.52241
Published online: 18 March 2024

Abstract

Objectives: To project how many minimal trauma fractures could be averted in Australia by expanding the number and changing the operational characteristics of fracture liaison services (FLS).

Study design: System dynamics modelling.

Setting, participants: People aged 50 years or more who present to hospitals with minimal trauma fractures, Australia, 2020–31.

Main outcome measures: Numbers of all minimal trauma fractures and of hip fractures averted by increasing the FLS number (from 29 to 58 or 100), patient screening rate (from 30% to 60%), and capacity for accepting new patients (from 40 to 80 per service per month), and reducing the proportion of eligible patients who do not attend FLS (from 30% to 15%); cost per fracture averted.

Results: Our model projected a total of 2 441 320 minimal trauma fractures (258 680 hip fractures; 2 182 640 non‐hip fractures) in people aged 50 years or older during 2020–31, including 1 211 646 second or later fractures. Increasing the FLS number to 100 averted a projected 5405 fractures (0.22%; $39 510 per fracture averted); doubling FLS capacity averted a projected 3674 fractures (0.15%; $35 835 per fracture averted). Our model projected that neither doubling the screening rate nor reducing by half the proportion of eligible patients who did not attend FLS alone would reduce the number of fractures. Increasing the FLS number to 100, the screening rate to 60%, and capacity to 80 new patients per service per month would together avert a projected 13 672 fractures (0.56%) at a cost of $42 828 per fracture averted.

Conclusion: Our modelling indicates that increasing the number of hospital‐based FLS and changing key operational characteristics would achieve only moderate reductions in the number of minimal trauma fractures among people aged 50 years or more, and the cost would be relatively high. Alternatives to specialist‐led, hospital‐based FLS should be explored.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 Monash Centre for Health Research and Implementation, Monash University, Melbourne, VIC
  • 2 Monash Health, Melbourne, VIC
  • 3 Sax Institute, Sydney, NSW
  • 4 Monash University, Melbourne, VIC
  • 5 Garvan Institute of Medical Research, Sydney, NSW
  • 6 St Vincent's Hospital Sydney, Sydney, NSW
  • 7 Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne and Western Health, Melbourne, VIC
  • 8 Western Health, Melbourne, VIC
  • 9 Amgen Europe, Rotkreuz, Switzerland
  • 10 Healthy Bones Australia, Sydney, NSW
  • 11 Australian Institute of Health Innovation, Macquarie University, Sydney, NSW
  • 12 Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW
  • 13 Centre of Research Excellence in Medicines Intelligence, University of New South Wales, Sydney, NSW
  • 14 Concord Clinical School, University of Sydney, Sydney, NSW
  • 15 ANZAC Research Institute, University of Sydney, Sydney, NSW
  • 16 Brain and Mind Centre, University of Sydney, Sydney, NSW
  • 17 Computer Simulation and Advanced Research Technologies (CSART), Sydney, NSW


Correspondence: alicia.jones@monash.edu


Open access:

Open access publishing facilitated by Monash University, as part of the Wiley – Monash University agreement via the Council of Australian University Librarians.


Acknowledgements: 

This investigation was funded by Amgen Australia. It was overseen by an expert advisory panel, including a representative from the funder, with an independent chair. The funder contributed to the scope and design of this study, and preparation and review of the manuscript, but did not influence the collation, management, analysis, and interpretation of the data, or the decision to submit the manuscript for publication.

We thank Janet Sluggett (University of South Australia, Adelaide), Cathie Sherrington (Institute for Musculoskeletal Health, University of Sydney, Sydney), Matthew Jennings (Liverpool Hospital, Sydney), Henry Cutler (Centre for Health Economy, Macquarie University, Sydney), Jacqueline Close (Prince of Wales Hospital, Sydney), and Mark Heffernan (Western Sydney University, Sydney) for their contributions to the advisory group and modelling.

Competing interests:

Jo‐An Occhipinti is managing director of Computer Simulation and Advanced Research Technologies. Alicia Jones holds a National Health and Medical Research Council (NHMRC) postgraduate research scholarship (1169192). Markus J Seibel holds an NHMRC Investigator Grant for research into secondary fracture prevention (APP1196062). Sean Lybrand is an employee of Amgen Australia.

  • 1. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1991; 90: 107‐110.
  • 2. Watts JJ, Abimanyi‐Ochom J, Sanders KM. Osteoporosis costing all Australians: a new burden of disease analysis 2012 to 2022. Melbourne: Osteoporosis Australia, 2013. https://healthybonesaustralia.org.au/wp‐content/uploads/2022/09/burden‐of‐disease‐analysis‐2012‐2022.pdf (viewed Feb 2021).
  • 3. Australian Institute of Health and Welfare. Estimating the prevalence of osteoporosis in Australia (Cat. no. PHE 178). Canberra: AIHW, 2014. https://www.aihw.gov.au/reports/chronic‐musculoskeletal‐conditions/estimating‐the‐prevalence‐of‐osteoporosis‐in‐austr/summary (viewed Mar 2021).
  • 4. Akesson K, Marsh D, Mitchell PJ, et al; IOF Fracture Working Group. Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 2013; 24: 2135‐2152.
  • 5. McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2003; 14: 1028‐1034.
  • 6. Ganda K, Puech M, Chen JS, et al. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta‐analysis. Osteoporos Int 2013; 24: 393‐406.
  • 7. Redman A, Bartlett M; National Alliance for Secondary Fracture Prevention. Towards an integrated Australian osteoporosis secondary fracture prevention program [unpublished report]. Sydney: Sax Institute, 2019.
  • 8. Australian Department of Health. National Strategic Action Plan for Osteoporosis. 17 Oct 2019. https://www.health.gov.au/resources/publications/national‐strategic‐action‐plan‐for‐osteoporosis‐2019?language=en (viewed Mar 2021).
  • 9. Jones AR, Herath M, Ebeling PR, et al. Models of care for osteoporosis: a systematic scoping review of efficacy and implementation characteristics. eClinicalMedicine 2021; 38: 101022.
  • 10. Cooper MS, Palmer AJ, Seibel MJ. Cost‐effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int 2012; 23: 97‐107.
  • 11. Yates CJ, Chauchard MA, Liew D, et al. Bridging the osteoporosis treatment gap: performance and cost‐effectiveness of a fracture liaison service. J Clin Densitom 2015; 18: 150‐156.
  • 12. Milat A, Lee K, Conte K, et al. Intervention Scalability Assessment Tool: a decision support tool for health policy makers and implementers. Health Res Policy Syst 2020; 18: 1.
  • 13. Koorts H, Cassar S, Salmon J, et al. Mechanisms of scaling up: combining a realist perspective and systems analysis to understand successfully scaled interventions. Int J Behav Nutr Phys Act 2021; 18: 42.
  • 14. Homer JB, Hirsch GB. System dynamics modeling for public health: background and opportunities. Am J Public Health 2006; 96: 452‐458.
  • 15. Sterman JD. Learning from evidence in a complex world. Am J Public Health 2006; 96: 505‐514.
  • 16. Freebairn L, Rychetnik L, Atkinson J, et al. Knowledge mobilisation for policy development: implementing systems approaches through participatory dynamic simulation modelling. Health Res Policy Syst 2017; 15: 87.
  • 17. Australian Bureau of Statistics. Australian Demographic Statistics, Mar 2019 (3101.0). 19 Sept 2019. https://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3101.0Main+Features1Mar%202019 (viewed Mar 2021).
  • 18. Drug Utilisation Sub‐Committee (Australian Department of Health). Denosumab for osteoporosis: utilisation analysis using PBS data. Oct 2020. https://www.pbs.gov.au/industry/listing/participants/public‐release‐docs/2020‐10/denosumab‐analysis‐PBS‐and‐MI‐dusc‐prd‐2020‐10v2.PDF (viewed June 2021).
  • 19. Crandall CJ, Newberry SJ, Diamant A, et al. Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med 2014; 161: 711‐723.
  • 20. Reid IR. Efficacy, effectiveness and side effects of medications used to prevent fractures. J Intern Med 2015; 277: 690‐706.
  • 21. Medicare Benefits Schedule Review Taskforce. Second report from the Diagnostic Imaging Clinical Committee: bone densitometry. Aug 2016. https://www.health.gov.au/sites/default/files/documents/2021/06/final‐clinical‐committee‐report‐for‐diagnostic‐imaging‐bone‐densitometry.pdf (viewed Mar 2021).
  • 22. Australian Institute of Health and Welfare. Osteoporosis web pages data tables. 2019. https://www.aihw.gov.au/getmedia/e28cc715‐5aef‐42a4‐9034‐14ebff0ef919/osteoporosis‐2019_1.xlsx.aspx (viewed Mar 2021).
  • 23. Little EA, Eccles MP. A systematic review of the effectiveness of interventions to improve post‐fracture investigation and management of patients at risk of osteoporosis. Implement Sci 2010; 5: 80.
  • 24. Sale JEM, Beaton D, Posen J, et al. Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 2011; 22: 2067‐2082.
  • 25. Kolanu N, Brown AS, Beech A, et al. Natural language processing of radiology reports improves identification of patients with fracture. Arch Osteoporos 2021; 16: 6.
  • 26. Blaker K, Wijewardene A, White E, et al. Electronic search programs are effective in identifying patients with minimal trauma fractures. Osteoporos Int 2022; 33: 435‐441.
  • 27. Reid IR, Horne AM, Mihov B, et al. Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 2018; 379: 2407‐2416.
  • 28. de Villiers TJ, Stevenson JC. The WHI: the effect of hormone replacement therapy on fracture prevention. Climacteric 2012; 15: 263‐266.
Online responses are no longer available. Please refer to our instructions for authors page for more information.

The provision of general surgery in rural Australia: a narrative review

Jessica Paynter, Kirby R Qin, Janelle Brennan, David J Hunter‐Smith and Warren M Rozen
Med J Aust || doi: 10.5694/mja2.52232
Published online: 4 March 2024

Summary

  • Rural surgery is most commonly provided by general surgeons to the 29% of people (7 million) living in rural Australia.
  • The provision of rural general surgery to enable equitable and safe surgical care for rural Australians is a multifaceted issue concerning recruitment, training, retention, surgical procedures and surgical outcomes.
  • Sustaining the rural general surgical workforce will be dependent upon growing an increased number of resident rural general surgeons, as well as changed models of care, with a need for ongoing review to track the outcomes of these changes.
  • To increase recruitment, rural general surgical training must improve to be less stressful for trainees and to be incorporated alongside a rural‐facing generalist curriculum.
  • Rural general surgical outcomes (excluding some oncology conditions) achieve comparable results to metropolitan centres.
  • Access to, and outcomes of, surgical oncology services continues to be inequitable for rural Australians and should be a major focus for improved service delivery.

Please login with your free MJA account to view this article in full


Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.


  • 1 Monash Rural Health — Bendigo, Monash University, Bendigo, VIC
  • 2 Bendigo Health, Bendigo, VIC
  • 3 Monash University, Melbourne, VIC


Correspondence: jess.paynter@monash.edu


Open access:

Open access publishing facilitated by Monash University, as part of the Wiley ‐ Monash University agreement via the Council of Australian University Librarians.


Competing interests:

No relevant disclosures.

  • 1. General Surgeons Australia. About us. Melbourne: GSA, 2022. https://www.generalsurgeons.com.au/about‐us (viewed Feb 2024).
  • 2. Royal Australasian College of Surgeons. Train for Rural: Rural Health Equity Strategy. Melbourne: RACS, 2021. https://www.surgeons.org/‐/media/Project/RACS/surgeons‐org/files/interest‐groups‐sections/Rural‐Surgery/2‐Train‐for‐Rural.pdf?rev=2e53ad7ecb3e4864be9dcc69e0556bb1&hash=6EF8D4FD8F5C13332C8C625D920E42C6 (viewed May 2023).
  • 3. Royal Australasian College of Surgeons. Activities report 2021. Melbourne: RACS, 2022. https://www.surgeons.org/‐/media/Project/RACS/surgeons‐org/files/reports‐guidelines‐publications/workforce‐activities‐census‐reports/2021‐12‐31_RACS_ActivitiesReport_2021_V4_Final.pdf?rev=7dced14774fa449e8a74b1023013998e&hash=528EC8EDAD1B41E0B2757EEECEAC97DF (viewed May 2023).
  • 4. Clancy B. Royal Australasian College of Surgeons Rural Health Equity Strategic Action Plan: excellence through equity. ANZ J Surg 2022; 92: 1990‐1994.
  • 5. Chong A, Kiroff G. Preparing surgeons for rural Australia: the RACS Rural Surgical Training Program. ANZ J Surg 2015; 85: 108‐112.
  • 6. Department of Health and Aged Care. Australian Statistical Geography Standard – Remoteness Area [website]. Canberra: Commonwealth of Australia, 2021. https://www.health.gov.au/topics/rural‐health‐workforce/classifications/asgs‐ra (viewed May 2023).
  • 7. Department of Health and Aged Care. Health Workforce Dataset: Data Tool. Canberra: Commonwealth of Australia, 2020. https://hwd.health.gov.au/datatool/ (viewed May 2023).
  • 8. O'Sullivan B, McGrail M, Russell D. Rural specialists: the nature of their work and professional satisfaction by geographical location of work. Aust J Rural Health 2017; 25: 338‐346.
  • 9. Nelson PG. General surgical manpower, Victoria, Australia. Aust N Z J Surg 1991; 61: 576‐588.
  • 10. Choi MS, van der Mark MA, Hung K. The distribution and composition of colonoscopy providers in Australia. Cureus 2022; 14: e22104.
  • 11. Shanmugakumar S, Playford D, Burkitt T, et al. Is Western Australia's rural surgical workforce going to sustain the future? A quantitative and qualitative analysis. Aust Health Rev 2017; 41: 75‐81.
  • 12. Paynter JA, O'Sullivan B, Qin KR, et al. Characterizing the female general surgery workforce in rural and regional Australia. ANZ J Surg 2023; 93: 2283‐2284.
  • 13. Bruening MH, Maddern GJ. The provision of general surgical services in rural South Australia: a new model for rural surgery. ANZ J Surg 1998; 68: 764‐768.
  • 14. Chittleborough TJ, Lourensz K, Elliott M, et al. Outreach surgical consulting services in North East Victoria. Aust J Rural Health 2013; 21: 325‐328.
  • 15. Gruen RL, Bailie RS, Wang Z, et al. Specialist outreach to isolated and disadvantaged communities: a population‐based study. Lancet 2006; 368: 130‐138.
  • 16. Hughes‐Anderson W, Rankin SL, House J, et al. Open access endoscopy in rural and remote Western Australia: does it work? ANZ J Surg 2002; 72: 699‐703.
  • 17. Maurice AP, Punnasseril JEJ, King SE, Dodd BJ. Improving access to bariatric surgery for rural and remote patients: experiences from a state‐wide bariatric telehealth service in Australia. Obes Surg 2020; 30: 4401‐4410.
  • 18. Hussain R, Maple M, Hunter S, et al. The fly‐in fly‐out and drive‐in drive‐out model of health care service provision for rural and remote Australia: benefits and disadvantages. Rural Remote Health 2015; 15: 3068.
  • 19. Echuca Regional Health. About us. Echuca: Echuca Regional Health, 2021. https://erh.org.au/about/ (viewed May 2023).
  • 20. Venchiarutti RL, Tracy M, Clark JR, et al. Geographic variation in referral practices for patients with suspected head and neck cancer: A survey of general practitioners using a clinical vignette. Aust J Rural Health 2022; 30: 501‐511.
  • 21. Oh D, Wright C, Young CJ. Management of obstetric anal sphincter injury: Colorectal surgeons’ perspectives in Australia and New Zealand. Aust N Z J Obstet Gynaecol 2021; 61: 16‐21.
  • 22. Yeh J, Palamuthusingam P, Cameron D, Avramovic J. Impact of establishing a specialized hepatobiliary unit on liver resections in a non‐specialized tertiary centre in regional Australia. ANZ J Surg 2022; 92: 769‐773.
  • 23. Bishop CV, Drummond KJ. Rural neurotrauma in Australia: implications for surgical training. ANZ J Surg 2006; 76: 53‐59.
  • 24. Brims FJH, Kumarasamy C, Nash J, et al. Hospital‐based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021. BMJ Open Respir Res 2022; 9: e001157.
  • 25. Underhill C, Bartel R, Goldstein D, et al. Mapping oncology services in regional and rural Australia. Aust J Rural Health 2009; 17: 321‐329.
  • 26. Youl P, Philpot S, Moore J, Theile DE. Population‐based picture of breast reconstruction in Queensland, Australia. ANZ J Surg 2021; 91: 695‐700.
  • 27. Flitcroft K, Brennan M, Costa D, Spillane A. Documenting patterns of breast reconstruction in Australia: the national picture. Breast 2016; 30: 47‐53.
  • 28. Hall SE, Holman CDJ. Inequalities in breast cancer reconstructive surgery according to social and locational status in Western Australia. Eur J Surg Oncol 2003; 29: 519‐525.
  • 29. Flitcroft K, Brennan M, Spillane A. Principles of patient‐centred care and barriers to their implementation: a case study of breast reconstruction in Australia. Support Care Cancer 2020; 28: 1963‐1981.
  • 30. Collins IM, Lum C, Versace VL. Influence of socioeconomic factors and distance to radiotherapy on breast‐conserving surgery rates for early breast cancer in regional Australia; implications of change. Asia Pac J Clin Oncol 2018; 14: e224‐e230.
  • 31. Australian Society of Plastic Surgeons. ASPS Darwin Workforce Project impact report: 2022 — the second year. Sydney: ASPS, 2022. https://plasticsurgery.org.au/wp‐content/uploads/2023/05/Darwin‐second‐year‐impact‐report_FINAL.pdf (viewed May 2023).
  • 32. Bryant K, Dean N. Innovation in rural workforce strategies by a national surgical society: the ASPS experience. Australas J Plast Surg 2021; 4: 3‐5.
  • 33. General Surgeons Australia. Curriculum. Melbourne: GSA, 2022. https://www.generalsurgeons.com.au/education‐and‐training/curriculum (viewed May 2023).
  • 34. Bruening MH, Anthony AA, Maddern GJ. Surgical rotations in provincial South Australia: the trainees’ perspective. ANZ J Surg 2003; 73: 65‐68.
  • 35. Miller FJ, Miller CA, Fox AM, et al. Influence of training on the family. ANZ J Surg 2006; 76: 907‐911.
  • 36. Hippolyte‐Blake D, Dreschler A, Rose A, et al. A qualitative study of the incentives and barriers that influence preferences for rural placements during surgical training in Australia. ANZ J Surg 2022; 92: 341‐345.
  • 37. Chan LS, Scholes NJW, Jones M. Skin excisions: not so simple for the regionally based general surgical trainee. Aust J Rural Health 2011; 19: 205‐210.
  • 38. Wong K, Birks D. Operative experience in the Victorian general surgical training programme. ANZ J Surg 2003; 73: 1036‐1040.
  • 39. O'Grady G, Loveday B, Harper S, et al. Working hours and roster structures of surgical trainees in Australia and New Zealand. ANZ J Surg 2010; 80: 890‐895.
  • 40. Eley DS, Synnott R, Baker PG, Chater AB. A decade of Australian Rural Clinical School graduates — where are they and why? Rural Remote Health 2012; 12: 1937.
  • 41. General Surgeons Australia. Training Committee. Melbourne: GSA, 2023. https://www.generalsurgeons.com.au/training‐committees (viewed May 2023).
  • 42. Monash University. About the hubs. Melbourne: Monash University, 2022. https://www.monash.edu/medicine/rural‐health/hubs/about‐us#:~:text=The%20regional%20training%20hub%20concept,phase%20of%20regional%20medical%20education (viewed May 2023).
  • 43. McGrail MR, Doyle Z, Fuller L, et al. The pathway to more rural doctors: the role of universities. Med J Aust 2023; 219 (Suppl): S8‐S13. https://www.mja.com.au/journal/2023/219/3/pathway‐more‐rural‐doctors‐role‐universities
  • 44. Bappayya S, Chen F, Alderuccio M, Schwalb H. Caseload distribution of general surgeons in regional Australia: is there a role for a rural surgery sub‐specialization? ANZ J Surg 2019; 89: 672‐676.
  • 45. Campbell NA, Kitchen G, Campbell IA. Operative experience of general surgeons in a rural hospital. ANZ J Surg 2011; 81: 601‐603.
  • 46. Campbell NA, Franzi S, Thomas P. Caseload of general surgeons working in a rural hospital with outreach practice. ANZ J Surg 2013; 83: 508‐511.
  • 47. Liu J, Lei C, Reid J, et al. Extended scope of practice needed for Australian rural general surgeons: a review of South Australia's rural general surgical caseload and case mix. ANZ J Surg 2022; 93: 522‐527.
  • 48. Paynter JA, Qin KR, O'Brien A, et al. Rural general surgeon confidence with managing vascular emergencies: a national survey. Aust J Rural Health 2023; 31: 897‐905.
  • 49. Luck T, Treacy PJ, Mathieson M, et al. Emergency neurosurgery in Darwin: still the generalist surgeons’ responsibility. ANZ J Surg 2015; 85: 610‐614.
  • 50. Gilligan J, Reilly P, Pearce A, Taylor D. Management of acute traumatic intracranial haematoma in rural and remote areas of Australia. ANZ J Surg 2017; 87: 80‐85.
  • 51. Udovicich C, Page D, Huq M, Clifforth S. Neck of femur fracture management by general surgeons at a rural hospital. Australas Med J 2015; 8: 154‐160.
  • 52. General Surgeons Australia. PFET Program in Rural Surgery. Melbourne: GSA, 2023. https://www.generalsurgeons.com.au/post‐fellowship‐education‐training/rural‐program (viewed May 2023).
  • 53. Stewart GD, Long G, Tulloh BR. Surgical service centralisation in Australia versus choice and quality of life for rural patients. Med J Aust 2006; 185: 162‐163. https://www.mja.com.au/journal/2006/185/3/surgical‐service‐centralisation‐australia‐versus‐choice‐and‐quality‐life‐rural
  • 54. Liu J, Ting YY, Trochsler M, et al. Analysis of surgical mortality in rural South Australia: a review of four major rural hospital in South Australia. ANZ J Surg 2022; 92: 1681‐1691.
  • 55. Tocaciu S, Thiagarajan J, Maddern GJ, Wichmann MW. Mortality after emergency abdominal surgery in a non‐metropolitan Australian centre. Aust J Rural Health 2018; 26: 408‐415.
  • 56. Swift K, Thompson F, Roeder L, et al. Appendicitis in Far North Queensland: a new take on an old story. ANZ J Surg 2022; 92: 114‐120.
  • 57. Quinn L, Read D. Paediatric surgical services in remote northern Australia: an integrated model of care. ANZ J Surg 2017; 87: 784‐788.
  • 58. Davis SS, Babidge WJ, Kiermeier A, Maddern GJ. Regional versus metropolitan pancreaticoduodenectomy mortality in Australia. ANZ J Surg 2019; 89: 1582‐1586.
  • 59. Davis SS, Noll D, Patel P, et al. Gastrectomy mortality in Australia. ANZ J Surg 2022; 92: 2109‐2114.
  • 60. Gray AD, Petrou G, Rastogi P, et al. Elective hepatic resection is feasible and safe in a regional centre. ANZ J Surg 2018; 88: E147‐E151.
  • 61. van Leeuwen MT, Falster MO, Vajdic CM, et al. Reoperation after breast‐conserving surgery for cancer in Australia: statewide cohort study of linked hospital data. BMJ Open 2018; 8: e020858.
  • 62. Hall S, Holman CDA, Sheiner H, Hendrie D. The influence of socio‐economic and locational disadvantage on survival after a diagnosis of lung or breast cancer in Western Australia. J Health Serv Res Policy 2004; 9 (Suppl): 10‐16.
  • 63. Fox PN, Chatfield MD, Beith JM, et al. Factors delaying chemotherapy for breast cancer in four urban and rural oncology units. ANZ J Surg 2013; 83: 533‐538.
  • 64. Marsh C, Wang J, Kollias J, et al. Disparities in access to breast care nurses for breast surgeons: a National Breast Cancer Audit survey. Breast 2010; 19: 142‐146.
  • 65. Marsh CJ, Boult M, Wang JX, et al. National Breast Cancer Audit: the use of multidisciplinary care teams by breast surgeons in Australia and New Zealand. Med J Aust 2008; 188: 385‐386. https://www.mja.com.au/journal/2008/188/7/national‐breast‐cancer‐audit‐use‐multidisciplinary‐care‐teams‐breast‐surgeons
  • 66. Bergin RJ, Thomas RJS, Whitfield K, White V. Concordance between Optimal Care Pathways and colorectal cancer care: identifying opportunities to improve quality and reduce disparities. J Eval Clin Pract 2020; 26: 918‐926.
  • 67. Watson MM, South Australian Rural Surgical Research Group, Watson DC, et al. Quality of rural colonoscopy outperforms key performance indicators in a multi‐centre prospective clinical study. ANZ J Surg 2022; 93: 528‐533
  • 68. Hoskins W, Taylor P, Jacob A, et al. Colectomies performed at a rural Australian hospital: a 7‐year analysis. Aust J Rural Health 2013; 21: 279‐284.
  • 69. Wichmann MW, McCullough TK, Beukes E, et al. Outcomes of laparoscopic colorectal cancer surgery in a non‐metropolitan Australian hospital: audit of 120 patients with long‐term follow‐up results. ANZ J Surg 2022; 92: 3214‐3218.
  • 70. Wichmann MW, McCullough TK, Beukes E, et al. Colorectal cancer surgery in rural Australia can match outcomes in metropolitan hospitals: a 14‐year study. Med J Aust 2021; 214: 186‐187. https://www.mja.com.au/journal/2021/214/4/colorectal‐cancer‐surgery‐rural‐australia‐can‐match‐outcomes‐metropolitan
  • 71. Udayasiri DK, MacCallum C, Da Silva N, et al. Impact of hospital geographic remoteness on overall survival after colorectal cancer resection using state‐wide administrative data. ANZ J Surg 2020; 90: 1321‐1327.
  • 72. O'Sullivan BG, Worley P. Setting priorities for rural allied health in Australia: a scoping review. Rural Remote Health 2020; 20: 5719.
  • 73. Mannix K. The future of Australia's nursing workforce: COVID‐19 and burnout among nurses. Melbourne: University of Melbourne, 2021. https://www.unimelb.edu.au/__data/assets/pdf_file/0004/4085194/katelyn_mannix_report.pdf (viewed May 2023).
  • 74. Parlier AB, Galvin SL, Thach S, et al. The road to rural primary care: a narrative review of factors that help develop, recruit, and retain rural primary care physicians. Acad Med 2018; 93: 130‐140.
  • 75. Ostini R, McGrail MR, Kondalsamy‐Chennakesavan S, et al. Building a sustainable rural physician workforce. Med J Aust 2021; 215 (Suppl): S1‐S33. https://www.mja.com.au/journal/2021/215/1/building‐sustainable‐rural‐physician‐workforce
Online responses are no longer available. Please refer to our instructions for authors page for more information.

Pagination

Subscribe to